From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Private Eye may be illiterate but it recognizes an “influential investment website” when it sees one

By Tom Winnifrith | Monday 19 February 2024

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Thanks to kind reader A, I bring you a page from this week’s Private Eye where it appears to recognize the good work done by this website even if it cannot actually spell our name. Poor Uncle Chris, who co-founded the Eye, will yet again spin in his grave. The article concerns the woes of struck off dentist Ajan Rejinald which we have exposed on this website and which the Eye is now regurgitating. As is always the case, but especially with the Novacyt (NCYT) trial looming, anyone owning shares in Rejinald’s Roquefort (ROQ) needs their head examining.

This story is available to all readers
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



Anpario – a recovery Buy?...

Thursday »


Bearcast issue update: all should be well



Oracle Power: Cynical Foul

Time left: 22:53:45